Jeremy Walsh
Jeremy Walsh is the head of artificial intelligence at the U.S. Food and Drug Administration (FDA), where he oversees the development and deployment of AI tools like Elsa, which aims to streamline drug and medical device approvals. Despite the potential benefits, Walsh has acknowledged the challenges of AI, including its tendency to generate false information, commonly referred to as 'hallucinations'. He emphasizes the importance of addressing these issues to improve the accuracy and reliability of AI in regulatory processes.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 5.00 | 0.03% | +0% | 331,002,651 | 102,319 | $21,000,000 | 6,491$ |
| Totals | 1 | 331,002,651 | 102,319 | $21,000,000 | 6,491$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
The FDA’s head of AI, Jeremy Walsh, admitted that Elsa can hallucinate nonexistent studies.
5